✦ LIBER ✦

Intravenous vinorelbine (i.v.VRL) and estramustine (EMP) in patients (pts) with androgen-independent prostate cancer (AIPC): final results

✍ Scribed by J. Carles; R. Bastus; J. Martin-Broto; P. Maroto; M. Nogue; M. Domenech; A. Arcusa; J. Bellmunt; A. Girard

Book ID: 117658665
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 194 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81303-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABEL

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABELED ANTI- PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) MONOCLONAL ANTIBODY J591 (177Lu-J591) IN PATIENTS (PTS) WITH METASTATIC ANDROGEN-INDEPENDENT PROSTATE CANCER (AIPC)

✍ Bander, Neil H; Nanus, David M; Tagawa, Scott; Vallabhajosula, Shankar; Goldsmit 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB

Inhibition of 20S proteasome results in

Inhibition of 20S proteasome results in serum IL-6 and PSA decline in patients (pts) with androgen-independent prostate cancer (AIPCa) treated with the proteasome inhibitor PS-341

✍ C. Papandreou; D. Daliani; R. Millikan; S. Tu; L. Pagliaro; J. Adams; P. Elliot; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Intermittent chemotherapy in patients wi

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel: Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Chi KN, Young J, Henner WD, ASCENT (AIPC Study of Calcitriol Enhancing Taxotere) Investigators, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR

✍ Donald L. Trump 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB